Our leadership team
Diverse leadership team with the experience to scale
Our passion is people, giving the best to our teams, patients and our partners.
Manuel O. Méndez
Chief Executive Officer
Ali Kiboro
Chief Financial Officer
Dr. Christian Fischer
Chief Scientific, Medical & Regulatory Affairs Officer
Sophie Bechu
Chief Operating Officer
Dr. Michael Hausmann
Chief Technology Officer
Viviane Montarnal
General Counsel & Compliance Officer
Steven Zuiderwijk
Chief Strategy & Marketing Officer
Mark Wheeler
Head of Customer Service & Support
David TenBarge
General Manager, Transfusion Business
Matt Howson
Chief Manufacturing Operations Officer, Clinical Business
Erika Abondano
Head of Human Resources
Trending Topics
Recent press, briefings and insights helping you stay informed on AliveDx news.
-
AliveDx Suisse S.A. and Bio-Strategy, part of DKSH Group, sign a distribution agreement for Australia and New Zealand
AliveDx Suisse S.A. and Bio-Strategy, part of DKSH Group, have signed a distribution agreement, which will enable Bio-Strategy to distribute the LumiQ™ solution in Australia and New Zealand. The distribution agreement takes effect immediately. This partnership underscores AliveDx’s dedication to
-
Join us at EuroMedLab 2025
We are excited to announce our participation in the upcoming EuroMedLab Congress in Brussels, Belgium, from 19-22 May 2025. Visit us at booth #245 to learn more about our MosaiQ® and LumiQ™ innovative, turnkey, fully automated autoimmune diagnostic solutions. The
-
AliveDx announces US FDA 510(k) submission for MosaiQ AiPlex® Connective Tissue Diseases (CTDplus) multiplex microarray
Eysins, Switzerland, 3 April 2025 – Today, AliveDx announces it has submitted 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) for the MosaiQ AiPlex® Connective Tissue Diseases (CTDplus) microarray. The MosaiQ AiPlex CTDplus multiplex assay, which received
-
AliveDx Suisse S.A. and Disera Tibbi Malzeme Lojistik. san. Tic. A.S sign Distribution Agreement in Türkiye
AliveDx Suisse S.A. and Disera Tibbi Malzeme Lojistik. san. Tic. A.S have signed a distribution agreement, which will enable Disera to distribute the MosaiQ® and LumiQ™ solutions in Türkiye. The distribution agreement takes effect immediately. This strategic partnership with an
-
AliveDx Suisse S.A. and Vital Care SPA sign distribution agreement in Algeria
AliveDx Suisse S.A. and Vital Care Prod SPA have signed a distribution agreement, which will enable Vital Care to distribute the MosaiQ® and LumiQ™ solutions in Algeria. The distribution agreement takes effect immediately. This partnership underscores AliveDx’s dedication to broadening
-
Alba Bioscience Limited and Medline Industries, LP sign distribution agreement for Alba reagents in the USA
Alba Bioscience Limited and Medline Industries, LP have signed a distribution agreement, which will enable Medline to distribute Alba’s range of reagents in the USA. The distribution agreement takes effect immediately. Alba develops and manufactures high-quality blood bank reagents for
